Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
Status:
Recruiting
Trial end date:
2028-08-01
Target enrollment:
Participant gender:
Summary
This is a phase III, multicenter, interventional and randomized study which evaluates the use
of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) coupled with either Primary Debulking
Surgery (PDS) or Interval Debulking Surgery (IDS), in patients with ovarian cancer. This
study aims to assess the efficacy, in terms of disease-free survival (DFS), the use of HIPEC
combined with standard care (PDS or IDS) or standard care alone.